You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Padeliporfin for untreated localised prostate cancer

  • Technology appraisal guidance
  • Reference number: TA546
  • Published:  21 November 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft guidance: 1
  4. Invitation to participate
  5. Draft scope documents

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 236 KB)

    Published:
    21 November 2018

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 417 KB)

    Published:
    12 October 2018
  • Committee papers (PDF 2.03 MB)

    Published:
    12 October 2018
  • Public committee slides (PDF 1.23 MB)

    Published:
    12 October 2018

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (PDF 507 KB)

    Published:
    02 July 2018
  • Public committee slides (PDF 1.21 MB)

    Published:
    02 July 2018
  • Committee papers (PDF 4.63 MB)

    Published:
    02 July 2018

Invitation to participate

  • Final scope (PDF 85 KB)

    Published:
    03 January 2018
  • Final matrix (PDF 89 KB)

    Published:
    03 January 2018
  • NICE's response to comments on the draft scope and provisional matrix (PDF 104 KB)

    Published:
    03 January 2018
  • Equality impact assessment (Scoping) (PDF 76 KB)

    Published:
    03 January 2018

Draft scope documents

  • Draft scope (pre-referral) (PDF 120 KB)

    Published:
    03 June 2016
  • Provisional matrix (pre-referral) (PDF 98 KB)

    Published:
    03 June 2016
Back to top